Role of Laparoscopic Surgery in the Management of Endometrial Cancer

2009 ◽  
Vol 7 (5) ◽  
pp. 559-567 ◽  
Author(s):  
Meaghan Tenney ◽  
Joan L. Walker

Minimum surgical treatment for endometrial cancer is removal of the uterus. The operative approach to achieve that goal ranges from vaginal hysterectomy alone to laparotomy with radical hysterectomy, bilateral salpingoophorectomy, bilateral pelvic and para-aortic lymphadenectomy with possible omentectomy, and resection of all metastatic disease. Stratifying the risk factors for predicting presence of metastatic disease has error rates exceeding tolerance for many gynecologic oncologists. Most accept routine laparoscopic surgical staging with hysterectomy, pelvic and para-aortic lymphadenectomy, and removal of adnexa as standard care for patients with endometrial cancer. Modifying the extent of surgical staging for low-risk intrauterine findings or excessive risk for postoperative morbidity is also accepted. Laparoscopic surgery has become the ideal initial surgical approach for this disease, allowing for visual inspection of common metastatic sites, biopsy of abnormal areas, and cytology from peritoneal surfaces. The extent of staging can be altered depending on frozen section findings from the uterus, adnexa, and peritoneal surfaces. Intraoperative medical decision-making can be individualized, encompassing all known risk factors for metastases and balancing comorbidities and potential adverse outcomes. This article documents how laparoscopic surgery satisfies the needs of individual patients and surgeons treating this disease.

2016 ◽  
Vol 26 (5) ◽  
pp. 918-923 ◽  
Author(s):  
Xiaoyuan Wang ◽  
Li Li ◽  
Janiel M. Cragun ◽  
Setsuko K. Chambers ◽  
Kenneth D. Hatch ◽  
...  

ObjectiveThe aim of this study was to assess the role of intraoperative frozen section (FS) in guiding decision making for surgical staging of endometrioid endometrial cancer (EC).MethodsMedical records were collected retrospectively on 112 patients with endometrioid EC, who underwent total hysterectomy and bilateral salpingo-oophorectomy at the University of Arizona Medical Center from January 1, 2010, to December 31, 2014. Only patients with endometrioid adenocarcinoma, grade 1, less than 50% myometrial invasion, and tumor size less than 2 cm determined by intraoperative FS omitted lymphadenectomy; otherwise, surgical staging was performed with lymph node dissection. The FS results were compared with the permanent paraffin sections (PSs) to assess the diagnostic accuracy.ResultsThe concordance rate of different variables between FS and PS in EC was 100%, 89.3% (100/112), 97.3% (109/112), and 95.5% (107/112), respectively, with respecting to histological subtype, grade, myometrial invasion, and tumor size. Diagnostic accurate rate of combined risk factors deciding surgical staging at the time of FS was 95.5% (107/112), and the discordance rate of all risk factors considered between FS and PS was 4.5%, resulting 3 cases (2.7%) undertreated and 2 cases (1.8%) overtreated.ConclusionsDespite nonideal FS evaluation, intraoperative FS diagnosis for EC is highly reliable by providing guidance for the intraoperative decisions of surgical staging at our institution, and such guidelines may be referenced by the institutions with sufficient gynecologic pathology expertise.


Author(s):  
Gülşen Doğan Durdağ ◽  
Songül Alemdaroğlu ◽  
Filiz Aka Bolat ◽  
Şafak Yılmaz Baran ◽  
Seda Yüksel Şimşek ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Wenting Li ◽  
Jie Jiang ◽  
Yu Fu ◽  
Yuanming Shen ◽  
Chuyao Zhang ◽  
...  

Objective: To systematically evaluate lymph node metastasis (LNM) patterns in patients with endometrial cancer (EC) who underwent complete surgical staging, which included systematic pelvic and para-aortic lymphadenectomy.Methods: Four thousand and one patients who underwent complete surgical staging including systematic pelvic and para-aortic lymphadenectomy for EC were enrolled from 30 centers in China from 2001 to 2019. We systematically displayed the clinical and prognostic characteristics of patients with various LNM patterns, especially the PLN-PAN+ [para-aortic lymph node (PAN) metastasis without pelvic lymph node (PLN) metastasis]. The efficacy of PAN+ (para-aortic lymph node metastasis) prediction with clinical and pathological features was evaluated.Results: Overall, 431 of the 4,001 patients (10.8%) showed definite LNM according to pathological diagnosis. The PAN+ showed the highest frequency (6.6%) among all metastatic sites. One hundred fourteen cases (26.5%) were PLN-PAN+ (PAN metastasis without PLN metastasis), 167 cases (38.7%) showed PLN+PAN-(PLN metastasis without PAN metastasis), and 150 cases (34.8%) showed metastasis to both regions (PLN+PAN+). There was also 1.9% (51/2,660) of low-risk patients who had PLN-PAN+. There are no statistical differences in relapse-free survival (RFS) and disease-specific survival (DSS) among PLN+PAN-, PLN-PAN+, and PLN+PAN+. The sensitivity of gross PLNs, gross PANs, and lymphovascular space involvement (LVSI) to predict PAN+ was 53.8 [95% confidence interval (CI): 47.6–59.9], 74.2 95% CI: 65.6–81.4), and 45.8% (95% CI: 38.7–53.2), respectively.Conclusion: Over one-fourth of EC patients with LMN metastases were PLN-PAN+. PLN-PAN+ shares approximate survival outcomes (RFS and DSS) with other LNM patterns. No effective clinical methods were achieved for predicting PAN+. Thus, PLN-PAN+ is a non-negligible LNM pattern that cannot be underestimated in EC, even in low-risk patients.


PLoS ONE ◽  
2011 ◽  
Vol 6 (9) ◽  
pp. e21912 ◽  
Author(s):  
Sanjeev Kumar ◽  
Sudeshna Bandyopadhyay ◽  
Assaad Semaan ◽  
Jay P. Shah ◽  
Haider Mahdi ◽  
...  

2003 ◽  
Vol 21 (1) ◽  
pp. 78-84 ◽  
Author(s):  
John C. Breneman ◽  
Elizabeth Lyden ◽  
Alberto S. Pappo ◽  
Michael P. Link ◽  
James R. Anderson ◽  
...  

Purpose: To identify risk factors associated with outcomes in children with metastatic rhabdomyosarcoma (RMS) treated on the fourth Intergroup Rhabdomyosarcoma Study (IRS-IV). Patients and Methods: Patients with metastatic RMS were treated with one of two regimens that incorporated a window of either ifosfamide and etoposide (IE) with vincristine, dactinomycin, and cyclophosphamide (VAC) or vincristine, melphalan (VM) and VAC. Study end points were failure-free survival (FFS) and overall survival (OS). Clinical factors including age, histology, sites of primary and metastatic disease, and number of sites of metastatic disease were correlated with those end points. Results: One hundred twenty-seven patients were eligible for analysis. The estimated 3-year OS and FFS for all patients were 39% and 25%, respectively. By univariate analysis, 3-year OS was significantly influenced by histology (47% for embryonal v 34% for all others, P = .026) and increasing number of metastatic sites (P = .028). By multivariate analysis, the presence of two or fewer metastatic sites was the only significant predictor (P = .007 and .006, respectively). The combination of embryonal histology with two or fewer metastatic sites identified a subgroup with 3-year FFS of 40% and OS of 47%. Conclusion: Children with group IV RMS treated on the IRS-IV study had improved OS and FFS if they had two or fewer metastatic sites and embryonal histology. This favorable subset of patients has outcomes approaching those observed in selected patients with localized, nonmetastatic disease. Thus, these patients might not be appropriate candidates for regimens that include experimental agents with substantial toxicities or unproven antitumor activity.


2021 ◽  
Vol 27 (Supplement_1) ◽  
pp. S36-S37
Author(s):  
Elida Voth ◽  
Srishti Saha ◽  
Laura Raffals ◽  
Darrell Pardi ◽  
Sahil Khanna

Abstract Background Immune checkpoint inhibitor (ICPI)-mediated diarrhea and colitis is the leading cause of discontinuation of ICPI therapy in patients with malignancy. Existing literature on predictors of adverse outcomes is limited. We evaluated the association between risk factors, concomitant Clostridioides difficile infection (CDI), and abdominal CT scan findings of colitis on outcomes in patients with ICPI-related diarrhea and colitis. Methods A retrospective study was conducted for patients who received an ICPI for treatment of malignancy and developed diarrhea or colitis, with endoscopic findings consistent with ICPI colitis. Variables including smoking history, proton pump inhibitor (PPI) use, non-steroidal anti-inflammatory (NSAID) use, concomitant CDI, and abdominal CT scan findings were extracted. The Common Terminology Criteria for Adverse Events (CTCAE) criteria was used to determine diarrhea and colitis severity. We analyzed the effect on risk factors on outcomes including hospitalization rates, diarrhea and colitis severity, and mortality at 1 year. Statistical analysis comprised of descriptive statistics and univariate and multivariate logistic regression analyses. Results There were 33 patients with histologically proven ICPI-related colitis with median age 70 years (28–92). Seventeen patients (52%) had melanoma and 24 patients (73%) had metastatic disease (Table 1). There was no association between age, gender, smoking history, PPI use, NSAID use on rates of hospitalization, toxicity severity, or mortality related to ICPI-related diarrhea or colitis (p>0.05) on univariate analysis. CDI at diagnosis was associated with a higher grade of toxicity (p=0.04) and higher rate of mortality at 1-year follow-up (p=0.03) compared to patients with a negative GI pathogen panel; however, this effect was not seen on multivariate analysis controlling for age and cancer stage (p>0.05). In patients with metastatic malignancy, there were significant higher rates of hospitalization for ICPI-colitis compared to those without metastatic disease on multivariate analysis controlling for age (OR, 4.53 [95% CI, 1.11–35.99]). In patients with CT scan findings consistent with colitis, there was a significantly higher rate of hospitalization compared to patients without these imaging findings on multivariate analysis controlling for age and cancer stage (OR, 2.99 [95% CI, 1.22–6.64]). Conclusions Patients with metastatic malignancy or CT scan findings consistent with colitis had a significantly higher rate of hospitalization for ICPI colitis compared to patients with non-metastatic disease or without radiographic features of colitis. CDI at diagnosis was associated with mortality and higher grade of toxicity. Further investigation is needed to examine predictors of adverse outcomes with use of ICPI to reduce morbidity and mortality in this patient population.


Sign in / Sign up

Export Citation Format

Share Document